OraSure Technologies Inc (OSUR):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:OraSure Technologies Inc (OSUR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7033
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OraSure Technologies Inc (OraSure) is a manufacturer and distributor of oral fluid specimen collection devices, diagnostic products and other medical devices. Its product portfolio encompasses infectious disease tests for the detection of antibodies for the HIV and Hepatitis C virus; Ebola virus, Zika virus and antigens for influenza type A and type B. OraSure also sells immunoassay tests and reagents for insurance risk assessment, substance-abuse testing and forensic toxicology applications; and products for the cryosurgical removal of warts and several other benign skin lesions. The company distributes its products to hospitals, clinics, community-based organizations and other public health organizations, distributors, clinical laboratories, and commercial and industrial entities. The company sells its products through distributors in the Americas, Europe and Asia-Pacific. OraSure is headquartered in Bethlehem, Pennsylvania, the US.

OraSure Technologies Inc (OSUR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
OraSure Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
OraSure Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
OraSure Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
OraSure Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
OraSure Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
OraSure Technologies Inc, Medical Equipment, Deal Details 10
Partnerships 10
OraSure Technologies Enters Into Co-Development Agreement With Thermo Fisher 10
Equity Offering 11
Orasure Technologies Files Shelf Registration Statement For Public Offering Of Securities For US$200 Million 11
OraSure Technologies Completes Public Offering Of Common Stock For US$75 Million 12
OraSure Technologies Inc – Key Competitors 13
OraSure Technologies Inc – Key Employees 14
OraSure Technologies Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Financial Announcements 16
Aug 08, 2018: Orasure announces 2018 second quarter financial results 16
May 02, 2018: OraSure Reports 2018 First Quarter Financial Results 18
Feb 07, 2018: OraSure Announces Record 2017 Fourth Quarter and Full-Year Financial Results 20
Nov 01, 2017: OraSure Announces 2017 Third Quarter Financial Results 22
Aug 02, 2017: OraSure Announces 2017 Second Quarter Financial Results 24
May 03, 2017: OraSure Announces 2017 First Quarter Financial Results 26
Feb 08, 2017: OraSure Announces 2016 Fourth Quarter and Full-Year Financial Results 28
Corporate Communications 30
Jul 23, 2018: OraSure Technologies names vice president, corporate communications 30
May 04, 2018: OraSure Technologies Names Roberto Cuca As New Chief Financial Officer 31
Apr 10, 2018: OraSure Technologies Appoints New Senior Vice President, Business Development 32
Feb 02, 2018: OraSure Technologies Names Aradhana Sarin As Board Director 33
Jan 04, 2018: OraSure Technologies Announces Management Succession Plan 34
Jun 22, 2017: OraSure Technologies Appoints Mara G. Aspinall to Board of Directors 36
Feb 24, 2017: OraSure Technologies Announces Director Retirement 37
Legal and Regulatory 38
Feb 06, 2017: OraSure Technologies Announces Settlement of Litigation with Ancestry.comDNA 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
OraSure Technologies Inc, Medical Equipment, Key Facts, 2017 2
OraSure Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
OraSure Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
OraSure Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
OraSure Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
OraSure Technologies Inc, Deals By Market, 2012 to YTD 2018 8
OraSure Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
OraSure Technologies Enters Into Co-Development Agreement With Thermo Fisher 10
Orasure Technologies Files Shelf Registration Statement For Public Offering Of Securities For US$200 Million 11
OraSure Technologies Completes Public Offering Of Common Stock For US$75 Million 12
OraSure Technologies Inc, Key Competitors 13
OraSure Technologies Inc, Key Employees 14
OraSure Technologies Inc, Other Locations 15
OraSure Technologies Inc, Subsidiaries 15

List of Figures
OraSure Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
OraSure Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
OraSure Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
OraSure Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
OraSure Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
OraSure Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
OraSure Technologies Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[OraSure Technologies Inc (OSUR):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BlueFire Renewables Inc (BFRE):企業の財務・戦略的SWOT分析
    Summary BlueFire Renewables Inc (BlueFire) is a producer and distributor of renewable liquid fuels. The company develops concentrated acid hydrolysis technology process for the profitable conversion of cellulosic waste materials such as green waste to ethanol, and other viable alternatives to petrol …
  • Nickel Asia Corporation:企業の戦略・SWOT・財務情報
    Nickel Asia Corporation - Strategy, SWOT and Corporate Finance Report Summary Nickel Asia Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Diebold Nixdorf, Incorporated:企業の戦略・SWOT・財務分析
    Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • BioView Ltd (BIOV)-医療機器分野:企業M&A・提携分析
    Summary BioView Ltd (BioView) is a medical device company that develops, manufactures and markets automated cell imaging and analysis solutions, which incorporate proprietary imaging, analysis and review technology. The technology provides automatic control of fully motorized fluorescent and bright- …
  • AGL Energy Ltd:発電所・企業SWOT分析
    AGL Energy Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exe …
  • Schroders Plc:企業の戦略・SWOT・財務情報
    Schroders Plc - Strategy, SWOT and Corporate Finance Report Summary Schroders Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • A. O. Smith Corporation (AOS):企業の財務・戦略的SWOT分析
    A. O. Smith Corporation (AOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Collagen Solutions Plc (COS)-医療機器分野:企業M&A・提携分析
    Summary Collagen Solutions Plc (Collagen Solutions), formerly Healthcare Investment Opportunities Plc is a medical device company that develops, manufactures and supplies medical grade collagen biomaterials and components. The company offers sourcing and supply of high grade collagen; provision of f …
  • TSO3 Inc (TOS)-医療機器分野:企業M&A・提携分析
    Summary TSO3 Inc (TSO3) is a medical device company that designs develops, manufactures, markets and licenses sterilization processes for heat-sensitive medical devices. The company’s area of focus is sterile processing, which provides a replacement solution to other low temperature sterilization pr …
  • Berkshire Hathaway Energy:企業の戦略・SWOT・財務分析
    Berkshire Hathaway Energy - Strategy, SWOT and Corporate Finance Report Summary Berkshire Hathaway Energy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Dominion Resources Inc:発電所・企業SWOT分析
    Dominion Resources Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employ …
  • Fate Therapeutics Inc (FATE):製薬・医療:M&Aディール及び事業提携情報
    Summary Fate Therapeutics Inc (Fate Therapeutics) is a biopharmaceutical company that develops programmed cellular therapies for cancer and immune disorders. The company’s pipeline product candidates include cellular immunotherapy pipeline, immuno-oncology candidates, and immuno-regulatory candidate …
  • Duke Energy Corporation (DUK)-石油・ガス分野:企業M&A・提携分析
    Summary Duke Energy Corporation (Duke Energy) is an integrated energy utility that undertakes the generation, transmission, distribution and sale of electricity; transportation and sale of natural gas; and provision of related energy services in the Southeast and Midwest regions of the US. It also p …
  • FleetCor Technologies Inc:企業の戦略・SWOT・財務分析
    FleetCor Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary FleetCor Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Crohn’s & Colitis Foundation Inc-製薬・医療分野:企業M&A・提携分析
    Summary Crohn's & Colitis Foundation Inc (CCF) is a non-profit organization which focuses on providing treatments for crohn's disease and ulcerative colitis. The organization funds studies at medical institutions, nurture investigators, and finance underdeveloped areas of research. CCF’s partners in …
  • Dabur India Ltd (DABUR):企業の財務・戦略的SWOT分析
    Dabur India Ltd (DABUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • MiMedx Group Inc (MDXG)-医療機器分野:企業M&A・提携分析
    Summary MiMedx Group Inc (MiMedx) is a provider of bioactive healing products for tissue regeneration. The company’s products are used in the therapeutic areas of chronic wounds, dental, ophthalmology, spine, orthopedic surgery, sports medicine and urology. Its products help in reducing inflammation …
  • UGI Corporation (UGI)-石油・ガス分野:企業M&A・提携分析
    Summary UGI Corporation (UGI) is a holding company providing energy products and services. Through a network of subsidiaries, the company stores, transports, distributes and markets energy products and related services. It serves as a domestic and international retail distributor of propane and buta …
  • Industriens Pensionsforsikring AS:電力:M&Aディール及び事業提携情報
    Summary Industriens Pensionsforsikring AS (Industriens Pensionsforsikring) is an insurance service provider. The company offers member pension insurance and company pension insurance products. Its member pension insurance covers critical illness, loss of earning capacity, death, healthcare, insuranc …
  • Prana Biotechnology Ltd (PBT):製薬・医療:M&Aディール及び事業提携情報
    Summary Prana Biotechnology Ltd (Prana Biotech) is a developer of therapeutic drugs. The company is conducting research into Huntington disease, Alzheimer's disease and brain cancer, and other major age-related degenerative disorders. It is developing first-in-class therapies for the treatment of ne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆